Dr. Jonathan P. Terdiman is a Professor of Clinical Medicine and Surgery and the Chief of the Gastroenterology Division at UCSF. He earned his undergraduate degree from Princeton University in 1985 and his medical degree from the Columbia University College of Physicians and Surgeons in 1989. Dr. Terdiman completed his internal medicine residency and fellowships in both critical care medicine and gastroenterology at UCSF before joining the faculty in 1996.
Dr. Terdiman has a busy clinical practice in gastroenterology, with a focus on the management of patients with inflammatory bowel disease. In 2013 Dr Terdiman was elected to the UCSF Department of Medicine’s Master Clinician Council. Dr Terdiman has been named a Bay area Top Doctor by San Francisco Magazine for the past four years and counting. Dr Terdiman also is a leading teacher of clinical medicine. He has received numerous campus-wide teaching awards, and he is a past member of the Haile T Debas Academy of Medical Educators.
Dr. Terdiman’s primary research activities focus on the assessment and mitigation of the risk among patients and families with a genetic predisposition to gastrointestinal cancers. He also is actively engaged in projects assessing the safety and efficacy of new therapies for inflammatory bowel disease. Dr. Terdiman chairs the American Gastroenterological Association guideline panel on the proper use of immune modulators and biological drugs in the treatment of moderate to severe Crohn’s disease, and he is the senior author of a new AGA technical review on the management of moderate to severe ulcerative colitis .
In addition to his work at UCSF, Dr Terdiman has served on the board of trustees of the Northern California Chapter of the Crohn’s and Colitis Foundation of America (CCFA) for many years, and was board president from 2010-2012. In 2012 the chapter named Dr. Terdiman as a CCFA Champion of Hope. Dr Terdiman also is a member of the board of trustees of the Brandeis School of San Francisco.